GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Net Margin %

Genetron Holdings (Genetron Holdings) Net Margin % : -170.76% (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Genetron Holdings's Net Income for the three months ended in Jun. 2022 was $-35.13 Mil. Genetron Holdings's Revenue for the three months ended in Jun. 2022 was $20.57 Mil. Therefore, Genetron Holdings's net margin for the quarter that ended in Jun. 2022 was -170.76%.

The historical rank and industry rank for Genetron Holdings's Net Margin % or its related term are showing as below:


GTH's Net Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -12.8
* Ranked among companies with meaningful Net Margin % only.

Genetron Holdings Net Margin % Historical Data

The historical data trend for Genetron Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Net Margin % Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial -206.51 -209.03 -723.00 -93.29 -124.24

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -84.55 -110.78 -158.06 -170.76 -

Competitive Comparison of Genetron Holdings's Net Margin %

For the Diagnostics & Research subindustry, Genetron Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetron Holdings's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genetron Holdings's Net Margin % falls into.



Genetron Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genetron Holdings's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-115.955/93.335
=-124.24 %

Genetron Holdings's Net Margin for the quarter that ended in Jun. 2022 is calculated as

Net Margin=Net Income (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-35.132/20.574
=-170.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetron Holdings  (NAS:GTH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Genetron Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.